Revista nº 810

· 95 · Actualidad Médica · Número 810 · Mayo/Agosto 2020 Páginas 90 a 95 Diagnóstico clínico en pacientes con anticuerpos antifosfolípidos positivos Herreros Fernández-Arroyo. P et al. BIBLIOGRAFÍA 1. Sobrino Grande C, Villalobos Sánchez L, Valero Expósito M, García Villanueva MJ. Síndrome antifosfolípido. Medicine - Programa de Formación Médica Continuada Acreditado. marzo de 2017;12(27):1551-9. 2. Connors JM. Thrombophilia Testing and Venous Thrombosis. Longo DL, editor. N Engl J Med. 21 de septiembre de 2017;377(12):1177-87. 3. Ahluwalia J, Sreedharanunni S. The Laboratory Diagnosis of the Antiphospholipid Syndrome.Indian J Hematol Blood Transfus.marzo de 2017;33(1):8-14. 4. Stojanovich L, Kontic M, Djokovic A, Ilijevski N, Stanisavljevic N, Marisavljevic D. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels. ScandinavianJournal of Rheumatology. mayo de 2012;41(3):223-6. 5. Camargo EW, Freire PV, Silva CA, Santos NR dos, Mota LMH da, Pereira RMR, et al. Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke? Rheumatol Int. junio de 2012;32(6):1721-5. 6. Sahebari M, Rastin M, Boostani R, Forughipour M, Hashemzadeh K, Sadeghi SH. Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study. CRR. 12 de diciembre de 2018;15(1):59-66. 7. Duarte-García A, Romero-Díaz J, Juárez S, Cicero-Casarrubias A, Fragoso-Loyo H, Núñez-Alvarez C, et al. Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.Liossis S-N, editor. PLoS ONE. 3 de mayo de 2018;13(5):e0196487. 8. Hu Z, Jing X, Liu J, Li M, Ye Y, Chen Y. Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay. D’Auria S, editor. PLoS ONE. 23 de septiembre de 2016;11(9):e0163682. 9. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk- Beirska I, Grill D, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 19 de febrero de 2008;70(8):627-33. 10. Mehta N, Uchino K, Fakhran S, Sattar MA, Branstetter BF, Au K, et al. Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke Severity. Stroke. diciembre de 2008;39(12):3236-41. 11. Palomo I, Pereira J, Alarcón M, Vásquez M, Pinochet C, Vélez MT, et al. Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis.Clinical Rheumatology. 1 de abril de 2004;23(2):129-33. 12. Locht H, Wiik A. IgG and IgM isotypes of anti-cardiolipin and anti-β 2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events. ClinRheumatol. marzo de 2006;25(2):246-50. 13. Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, et al. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual: IgA anti-APL antibodies and clinical events in Swedish cases of SLE. ClinExpImmunol. octubre de 2018;194(1):27-38. 14. Samarkos M, Davies KA, Gordon C, Loizou S. Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. ClinRheumatol. marzo de 2006;25(2):199-204. 15. Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, et al. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.Thrombosis Research.noviembre de 2015;136(5):883-6. 16. Doley D, Kakati S, Saikia L, Rajadhyaksha A, Nadkar M, Khadilkar P, et al. A Comparitive Study of Anticardiolipin Antibodies among Systemic Lupus Erythematosus Patients fromWestern and Eastern India. Journal of The Association of Physicians of India. marzo de 2017;65:14-9.